- RecruitingPHASE3
Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
This study looks at two different doses of heated chemotherapy (HIPEC) for a rare cancer called PMP. We want to see if the lower dose, given for a shorter time, works just as well as the higher dose, which could mean fewer side effects for patients.
For: Pseudomyxoma PeritoneiUnited Kingdom - RecruitingPHASE3
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
This study compares a new treatment, TAR-210, with standard chemotherapy for high-risk bladder cancer that hasn't spread to the muscle. It aims to see which treatment best prevents the cancer from returning or getting worse.
For: Non-Muscle Invasive Bladder NeoplasmsUnited States · Argentina · Belgium - Active not recruitingPHASE3
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
This study compares a new treatment, TAR-200, with standard chemotherapy for a type of bladder cancer that has returned after initial treatment. It's for people who can't or won't have surgery to remove their bladder.
For: Non-Muscle Invasive Bladder NeoplasmsUnited States · Argentina · Belgium